SCHEMBL5464429

SCHEMBL5464429

CN1CCN(C(=O)NCc2cccc(F)c2)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.60
KMT2A Q03164 1/20 0.60
TP53 P04637 1/20 0.54
P2RY12 Q9H244 1/20 0.53
CHRM2 P08172 1/20 0.53
CHRM4 P08173 1/20 0.53
CHRM1 P11229 1/20 0.53
CHRM3 P20309 1/20 0.53
MAPK1 P28482 1/20 0.53
KDM4E B2RXH2 1/20 0.52
FAAH O00519 1/20 0.51
NAMPT P43490 1/20 0.51
DPP4 P27487 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
CASP3 P42574 1/20 0.50
PKM P14618 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
ATM Q13315 1/20 0.48
ALDH1A1 P00352 1/20 0.48
TSHR P16473 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5471326 0.86 MEN1 (0.62) MEN1KMT2ATP53KDM4ENAMPT
SCHEMBL5472340 0.84 KMT2A (0.60) MEN1KMT2AMAPK1KDM4EFAAH
SCHEMBL5472671 0.83 NPC1 (0.67) MEN1KMT2AFAAHPKM
SCHEMBL5474021 0.83 MEN1 (0.76) MEN1KMT2ATP53MAPK1KDM4E
SCHEMBL5471150 0.83 MEN1 (0.75) MEN1KMT2ATP53KDM4ESMN1; SMN2
SCHEMBL5464008 0.82 PKM (0.66) MEN1KMT2AFAAHNAMPTSMN1; SMN2
SCHEMBL5457520 0.80 NAMPT (0.56) MEN1KMT2ACHRM4CHRM3NAMPT
SCHEMBL23718574 0.80 MEN1 (0.56) MEN1KMT2ATP53KDM4ENAMPT
SCHEMBL5466519 0.80 KMT2A (0.67) MEN1KMT2ATP53KDM4EPKM
SCHEMBL24422954 0.79 ALDH1A1 (0.58) KMT2APKMALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249618-A1 Novel Piperidine Derivatives as Histamine H3 Receptor Ligands for Treatment of Depression ASTRAZENECA AB (SE) 2007-10-25 US disclosed
US-20070249618-A1 Novel Piperidine Derivatives as Histamine H3 Receptor Ligands for Treatment of Depression ASTRAZENECA AB (SE) 2007-10-25 US disclosed
US-20070249618-A1 Novel Piperidine Derivatives as Histamine H3 Receptor Ligands for Treatment of Depression ASTRAZENECA AB (SE) 2007-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249618-A1 Novel Piperidine Derivatives as Histamine H3 Receptor Ligands for Treatment of Depression HRH3, HRH1, HRH4 MEN1 3623/4885KMT2A 323/4885TP53 4618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.